Patent · US Active

FX activation process and its use in the preparation of a FXa composition

US12274738B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

OCTAPHARMA AG · CH

Inventors

Juergen Roemisch · Marburg, DE
Katharina Pock · Wien, AT
Petra Schulz · Wien, AT
Silvio WUSCHKO · Wien, AT
Michael ANDESNER · Wien, AT
Andrej MURANYI · Wien, AT

Key dates

Filing date	Jul 8, 2019
Grant date	Apr 15, 2025
Priority date	—
Expiry date	Oct 30, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21006
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a high purity Coagulation Factor Xa (FXa or activated Coagulation Factor X) preparation and an activation and purification process to obtain said FXa of high purity and high degree of activation without addition of proteinaceous activators during manufacturing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.